These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24241267)

  • 21. Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients.
    Holmes JA; Carpenter WR; Wu Y; Hendrix LH; Peacock S; Massing M; Schenck AP; Meyer AM; Diao K; Wheeler SB; Godley PA; Stitzenberg KB; Chen RC
    J Urol; 2012 Mar; 187(3):883-8. PubMed ID: 22248516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. African-American Prostate Cancer Disparities.
    Smith ZL; Eggener SE; Murphy AB
    Curr Urol Rep; 2017 Aug; 18(10):81. PubMed ID: 28808871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Realities of Prostate Cancer Screening, Treatment, and Race.
    Brawley OW; Paller CJ
    J Natl Cancer Inst; 2021 Oct; 113(10):1272-1273. PubMed ID: 33964161
    [No Abstract]   [Full Text] [Related]  

  • 24. Descriptive epidemiology of prostate cancer in metropolitan Detroit.
    Taylor JD; Holmes TM; Swanson GM
    Cancer; 1994 Mar; 73(6):1704-7. PubMed ID: 8156498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer screening and detection in inner-city and underserved men.
    Anai S; Pendleton J; Wludyka P; Williams C; Nelms L; Pettaway C; Rosser CJ
    J Natl Med Assoc; 2006 Apr; 98(4):515-9. PubMed ID: 16623063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial.
    Miller EA; Pinsky PF; Black A; Andriole GL; Pierre-Victor D
    Prostate; 2018 Aug; 78(11):830-838. PubMed ID: 29667217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma.
    Fowler JE; Bigler SA
    Cancer; 1999 Sep; 86(5):836-41. PubMed ID: 10463983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system.
    Optenberg SA; Thompson IM; Friedrichs P; Wojcik B; Stein CR; Kramer B
    JAMA; 1995 Nov 22-29; 274(20):1599-605. PubMed ID: 7474244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal and spatial trends and determinants of aggressive prostate cancer among Black and White men with prostate cancer.
    Wang M; Chi G; Bodovski Y; Holder SL; Lengerich EJ; Wasserman E; McDonald AC
    Cancer Causes Control; 2020 Jan; 31(1):63-71. PubMed ID: 31732913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing prostate cancer treatment decisions for African American and white men.
    Gordon BE; Basak R; Carpenter WR; Usinger D; Godley PA; Chen RC
    Cancer; 2019 May; 125(10):1693-1700. PubMed ID: 30695113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer: the stage disadvantage in the black male.
    Targonski PV; Guinan P; Phillips CW
    J Natl Med Assoc; 1991 Dec; 83(12):1094-6. PubMed ID: 1813640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in prognostic factors and survival among White men and Black men with prostate cancer, California, 1995-2004.
    Robbins AS; Yin D; Parikh-Patel A
    Am J Epidemiol; 2007 Jul; 166(1):71-8. PubMed ID: 17426038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer treatment patterns among racial/ethnic groups in Florida.
    Xiao H; Warrick C; Huang Y
    J Natl Med Assoc; 2009 Sep; 101(9):936-43. PubMed ID: 19806852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial disparities in treatment delay among younger men with prostate cancer.
    Jain B; Yamoah K; Lathan CS; Muralidhar V; Mahal BA; Nguyen PL; Dee EC
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):590-592. PubMed ID: 35190652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men.
    Gueye SM; Zeigler-Johnson CM; Friebel T; Spangler E; Jalloh M; MacBride S; Malkowicz SB; Rebbeck TR
    Urology; 2003 May; 61(5):987-92. PubMed ID: 12736021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demographic differences in prostate cancer incidence and stage: an examination of population diversity in California.
    Delfino RJ; Ferrini RL; Taylor TH; Howe S; Anton-Culver H
    Am J Prev Med; 1998 Feb; 14(2):96-102. PubMed ID: 9631160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial disparities in prostate cancer among black men: epidemiology and outcomes.
    Chowdhury-Paulino IM; Ericsson C; Vince R; Spratt DE; George DJ; Mucci LA
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):397-402. PubMed ID: 34475523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis.
    Evans S; Metcalfe C; Ibrahim F; Persad R; Ben-Shlomo Y
    Int J Cancer; 2008 Jul; 123(2):430-435. PubMed ID: 18452170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.
    Hoffman RM; Harlan LC; Klabunde CN; Gilliland FD; Stephenson RA; Hunt WC; Potosky AL
    J Gen Intern Med; 2003 Oct; 18(10):845-53. PubMed ID: 14521648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
    Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
    Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.